Literature DB >> 32114075

Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19).

Jaffar A Al-Tawfiq1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32114075      PMCID: PMC7102602          DOI: 10.1016/j.tmaid.2020.101608

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


× No keyword cloud information.
To the editor, The occurrence of asymptomatic individuals with coronaviruses or other viruses may pose a significant public health issue. A recent review in this journal showed that an increase in the rate of asymptomatic individuals with the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) increased from 0% to 28.6% [1]. Actually, as the MERS-CoV progressed overtime there was more identification of asymptomatic individuals due to increased surviellance and contacts testing. This increase had proportionally but inversely affected the case fatality rate. It is expected that early on the course of any outbreak that severe cases are recognized first and then less severe (mildly or asymptomatic) cases are detected with increasing frequency. The extent of asymptomatic MERS-CoV cases is about 9.8% from different studies, Table 1 [1].
Table 1

Extent of Asymptomatic MERS-CoV among tested individuals based on Reverse Transcriptase PCR, data are from Ref. [1].

SettingProportion of asymptomatic cases (%)
laboratory-confirmed and probable MERS-CoV cases from 9 countries18/144 (12.5%)
Extent of Asymptomatic MERS-CoV among tested individuals based on Reverse Transcriptase PCR, data are from Ref. [1]. A study of human rhinovirus showed that asymptomatic infection was four times as common as symptomatic infection [2] and another study showed that the rate of rhinovirus infection among a pair of asymptomatic parents of a rhinovirus symptomatic child was one of 36 (2.8%) with an overall positivity of 23.5% among symptomatic subjects and 3.6% of asymptomatic subjects [3]. Asymptomatic carriage of influenza virus was estimated to be 5.2%–35.5% [4] Based on serology, the positivity rate was 13% in asymptomatic SARS 4% in those with mild symptoms, and 82% in those with severe disease [5]. Since the emergence of SARS-COV-2, (known initially as 2019-nCoV), in Wuhan, China, in December 2019, the number of global cases had increased significantly. The increase in the number of cases is alarming and brought the fear of having viral transmission from asymptomatic individuals. One report indicated that an asymptomatic person was able to transmit the virus to another patient in Germany [6]. In addition, in a family cluster of cases who went to Wuhan from Shenzen, the parents and the grandparents who visited a family member in a hospital had symptoms and they tested positive for SARS-CoV-2 (2019-nCoV). The family insisted in testing a 10-year-old asymptomatic boy and the tests were positive as tested by RT-PCR in nasopharyngeal and throat swab samples and the CT-scan showed mild infiltrate [7]. The contribution of asymptomatic persons with MERS-CoV or SARS-CoV-2 to the transmission is not well characterized. Those asymptomatic cases may play a role in the transmission and thus pose a significant infection control challenge. However, the contribution of asymptomatic cases in the transmission of these viruses is not well known and deserve further studies to examine the extent of occurrence and the role in transmission. These studies should examine the clinical course of those individuals, viral dynamics, viral loads and contribution to the transmission. It is crucial to evaluate the burden of asymptomatic individuals. Such studies will enhance the understanding of the pathogenesis of these emerging viruses and will inform policy makers to make scientifically sound recommendations.

Funding source

None.

CRediT authorship contribution statement

Jaffar A. Al-Tawfiq: Conceptualization, Writing - original draft.

Declaration of competing interest

None.
  7 in total

1.  Asymptomatic SARS coronavirus infection among healthcare workers, Singapore.

Authors:  Annelies Wilder-Smith; Monica D Teleman; Bee H Heng; Arul Earnest; Ai E Ling; Yee S Leo
Journal:  Emerg Infect Dis       Date:  2005-07       Impact factor: 6.883

2.  Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.

Authors:  Camilla Rothe; Mirjam Schunk; Peter Sothmann; Gisela Bretzel; Guenter Froeschl; Claudia Wallrauch; Thorbjörn Zimmer; Verena Thiel; Christian Janke; Wolfgang Guggemos; Michael Seilmaier; Christian Drosten; Patrick Vollmar; Katrin Zwirglmaier; Sabine Zange; Roman Wölfel; Michael Hoelscher
Journal:  N Engl J Med       Date:  2020-01-30       Impact factor: 91.245

3.  Comparison of asymptomatic and symptomatic rhinovirus infections in university students: incidence, species diversity, and viral load.

Authors:  Andrea Granados; Emma C Goodall; Kathy Luinstra; Marek Smieja; James Mahony
Journal:  Diagn Microbiol Infect Dis       Date:  2015-05-07       Impact factor: 2.803

4.  Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: Extent and implications for infection control: A systematic review.

Authors:  Jaffar A Al-Tawfiq; Philippe Gautret
Journal:  Travel Med Infect Dis       Date:  2018-12-11       Impact factor: 6.211

5.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

6.  Human rhinovirus infections in symptomatic and asymptomatic subjects.

Authors:  C N Camargo; E Carraro; C F Granato; N Bellei
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

Review 7.  Heterogeneous and Dynamic Prevalence of Asymptomatic Influenza Virus Infections.

Authors:  Luis Furuya-Kanamori; Mitchell Cox; Gabriel J Milinovich; Ricardo J Soares Magalhaes; Ian M Mackay; Laith Yakob
Journal:  Emerg Infect Dis       Date:  2016-06       Impact factor: 6.883

  7 in total
  73 in total

1.  Emergency department response to COVID-19 outbreak with a fever screening station and "graded approach" for isolation and testing.

Authors:  Julia Chia-Yu Chang; You-Hsu Chen; Meng-Chen Lin; Yi-Jing Li; Teh-Fu Hsu; Hsien-Hao Huang; David Hung-Tsang Yen
Journal:  J Chin Med Assoc       Date:  2020-09-02       Impact factor: 2.743

2.  The Novel Coronavirus and Inflammation.

Authors:  J A George; E S Mayne
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Transport effect of COVID-19 pandemic in France.

Authors:  Lina Guan; Christophe Prieur; Liguo Zhang; Clémentine Prieur; Didier Georges; Pascal Bellemain
Journal:  Annu Rev Control       Date:  2020-10-05       Impact factor: 6.091

4.  SARS-CoV-2 Infection in Healthcare Professionals and General Population During "First Wave" of COVID-19 Pandemic: A Cross-Sectional Study Conducted in Sicily, Italy.

Authors:  Claudio Costantino; Emanuele Cannizzaro; Maria Gabriella Verso; Fabio Tramuto; Carmelo Massimo Maida; Guido Lacca; Davide Alba; Livia Cimino; Arianna Conforto; Luigi Cirrincione; Giorgio Graziano; Sara Palmeri; Stefano Pizzo; Vincenzo Restivo; Alessandra Casuccio; Francesco Vitale; Walter Mazzucco
Journal:  Front Public Health       Date:  2021-05-13

5.  Challenges for maintaining surgical care practices in the COVID-19 pandemic: an integrative review.

Authors:  José Erivelton de Souza Maciel Ferreira; Tahissa Frota Cavalcante; Raphaella Castro Jansen; Daniel Freitas Oliveira Damasceno; Lídia Rocha Oliveira; Maria Jocelane Nascimento Silva; Ana Paula Rodrigues
Journal:  Invest Educ Enferm       Date:  2022-03

6.  Viral RNA in City Wastewater as a Key Indicator of COVID-19 Recrudescence and Containment Measures Effectiveness.

Authors:  Nathalie Wurtz; Alexandre Lacoste; Priscilla Jardot; Alain Delache; Xavier Fontaine; Maxime Verlande; Alexandre Annessi; Audrey Giraud-Gatineau; Hervé Chaudet; Pierre-Edouard Fournier; Patrick Augier; Bernard La Scola
Journal:  Front Microbiol       Date:  2021-05-17       Impact factor: 5.640

7.  All five COVID-19 outbreaks during epidemic period of 2020/2021 in China were instigated by asymptomatic or pre-symptomatic individuals.

Authors:  Caixin Yang; Sihui Zhang; Shan Lu; Jing Yang; Yanpeng Cheng; Yue Liu; Lijun Zhao; Jian Gong; Jianguo Xu
Journal:  J Biosaf Biosecur       Date:  2021-05-21

8.  Using Machine Learning Algorithms to Develop a Clinical Decision-Making Tool for COVID-19 Inpatients.

Authors:  Abhinav Vepa; Amer Saleem; Kambiz Rakhshan; Alireza Daneshkhah; Tabassom Sedighi; Shamarina Shohaimi; Amr Omar; Nader Salari; Omid Chatrabgoun; Diana Dharmaraj; Junaid Sami; Shital Parekh; Mohamed Ibrahim; Mohammed Raza; Poonam Kapila; Prithwiraj Chakrabarti
Journal:  Int J Environ Res Public Health       Date:  2021-06-09       Impact factor: 3.390

Review 9.  How is the iceberg of COVID-19? Results from a rapid literature review.

Authors:  Ghobad Moradi; Fatemeh Gholami; Mohammad Aziz Rasouli; Fahimeh Bagheri Amiri; Yousef Moradi
Journal:  Med J Islam Repub Iran       Date:  2021-06-16

10.  Using postal change-of-address data to predict second waves in infections near pandemic epicentres.

Authors:  Adam Schulman; Gyan Bhanot
Journal:  Epidemiol Infect       Date:  2022-03-24       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.